JP2016535035A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016535035A5 JP2016535035A5 JP2016526866A JP2016526866A JP2016535035A5 JP 2016535035 A5 JP2016535035 A5 JP 2016535035A5 JP 2016526866 A JP2016526866 A JP 2016526866A JP 2016526866 A JP2016526866 A JP 2016526866A JP 2016535035 A5 JP2016535035 A5 JP 2016535035A5
- Authority
- JP
- Japan
- Prior art keywords
- agents
- agent
- drugs
- skin
- synthesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003795 chemical substances by application Substances 0.000 claims description 54
- 229940079593 drug Drugs 0.000 claims description 36
- 239000003814 drug Substances 0.000 claims description 36
- 239000000203 mixture Substances 0.000 claims description 25
- 230000015572 biosynthetic process Effects 0.000 claims description 22
- 238000003786 synthesis reaction Methods 0.000 claims description 22
- 239000002537 cosmetic Substances 0.000 claims description 21
- 210000003491 skin Anatomy 0.000 claims description 18
- 229920002444 Exopolysaccharide Polymers 0.000 claims description 14
- 241001420004 Halomonas anticariensis Species 0.000 claims description 12
- 239000002269 analeptic agent Substances 0.000 claims description 12
- 239000000021 stimulant Substances 0.000 claims description 12
- 230000003779 hair growth Effects 0.000 claims description 8
- 239000003112 inhibitor Substances 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 7
- 230000001225 therapeutic effect Effects 0.000 claims description 7
- 230000002265 prevention Effects 0.000 claims description 6
- 230000035755 proliferation Effects 0.000 claims description 6
- 208000035484 Cellulite Diseases 0.000 claims description 5
- 206010049752 Peau d'orange Diseases 0.000 claims description 5
- 102000010637 Aquaporins Human genes 0.000 claims description 4
- 108010063290 Aquaporins Proteins 0.000 claims description 4
- 102000008186 Collagen Human genes 0.000 claims description 4
- 108010035532 Collagen Proteins 0.000 claims description 4
- 102000016942 Elastin Human genes 0.000 claims description 4
- 108010014258 Elastin Proteins 0.000 claims description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 4
- 108010004889 Heat-Shock Proteins Proteins 0.000 claims description 4
- 102000002812 Heat-Shock Proteins Human genes 0.000 claims description 4
- 210000001789 adipocyte Anatomy 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 4
- 239000003429 antifungal agent Substances 0.000 claims description 4
- 210000004027 cell Anatomy 0.000 claims description 4
- 229920001436 collagen Polymers 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 4
- 230000004069 differentiation Effects 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 229920002549 elastin Polymers 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 4
- 210000002510 keratinocyte Anatomy 0.000 claims description 4
- 239000003410 keratolytic agent Substances 0.000 claims description 4
- 230000004130 lipolysis Effects 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- 239000003223 protective agent Substances 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 239000002516 radical scavenger Substances 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 239000003381 stabilizer Substances 0.000 claims description 4
- 230000000638 stimulation Effects 0.000 claims description 4
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims description 3
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims description 3
- 230000036232 cellulite Effects 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 230000006372 lipid accumulation Effects 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- NTQVODZUQIATFS-WAUHAFJUSA-N (2s)-2-[[(2s)-6-amino-2-[[2-[[(2s,3s)-2-[[(2s)-2-[[(2s)-2-amino-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]acetyl]amino]hexanoyl]amino]-3-methylbutanoic acid Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O NTQVODZUQIATFS-WAUHAFJUSA-N 0.000 claims description 2
- 102000008490 2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine Human genes 0.000 claims description 2
- 108010020504 2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine Proteins 0.000 claims description 2
- 239000002677 5-alpha reductase inhibitor Substances 0.000 claims description 2
- 235000007173 Abies balsamea Nutrition 0.000 claims description 2
- 102000012440 Acetylcholinesterase Human genes 0.000 claims description 2
- 108010022752 Acetylcholinesterase Proteins 0.000 claims description 2
- 201000004384 Alopecia Diseases 0.000 claims description 2
- 108090000991 Aquaporin 3 Proteins 0.000 claims description 2
- 102100037332 Aquaporin-3 Human genes 0.000 claims description 2
- 239000004857 Balsam Substances 0.000 claims description 2
- 208000035985 Body Odor Diseases 0.000 claims description 2
- 241000195940 Bryophyta Species 0.000 claims description 2
- 108010009685 Cholinergic Receptors Proteins 0.000 claims description 2
- 102000004127 Cytokines Human genes 0.000 claims description 2
- 108090000695 Cytokines Proteins 0.000 claims description 2
- 108020004414 DNA Proteins 0.000 claims description 2
- 230000033616 DNA repair Effects 0.000 claims description 2
- 102000004237 Decorin Human genes 0.000 claims description 2
- 108090000738 Decorin Proteins 0.000 claims description 2
- 102000000541 Defensins Human genes 0.000 claims description 2
- 108010002069 Defensins Proteins 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- 102000016359 Fibronectins Human genes 0.000 claims description 2
- 108010067306 Fibronectins Proteins 0.000 claims description 2
- 229940123457 Free radical scavenger Drugs 0.000 claims description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 2
- 101001123331 Homo sapiens Peroxisome proliferator-activated receptor gamma coactivator 1-alpha Proteins 0.000 claims description 2
- 102000004157 Hydrolases Human genes 0.000 claims description 2
- 108090000604 Hydrolases Proteins 0.000 claims description 2
- 244000018716 Impatiens biflora Species 0.000 claims description 2
- 102000002274 Matrix Metalloproteinases Human genes 0.000 claims description 2
- 108010000684 Matrix Metalloproteinases Proteins 0.000 claims description 2
- 239000004909 Moisturizer Substances 0.000 claims description 2
- 108010006519 Molecular Chaperones Proteins 0.000 claims description 2
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 claims description 2
- 102000008299 Nitric Oxide Synthase Human genes 0.000 claims description 2
- 108010021487 Nitric Oxide Synthase Proteins 0.000 claims description 2
- 102000000536 PPAR gamma Human genes 0.000 claims description 2
- 108010016731 PPAR gamma Proteins 0.000 claims description 2
- 102000035195 Peptidases Human genes 0.000 claims description 2
- 108091005804 Peptidases Proteins 0.000 claims description 2
- 102100028960 Peroxisome proliferator-activated receptor gamma coactivator 1-alpha Human genes 0.000 claims description 2
- 102000004079 Prolyl Hydroxylases Human genes 0.000 claims description 2
- 108010043005 Prolyl Hydroxylases Proteins 0.000 claims description 2
- 229940123575 Protein synthesis stimulant Drugs 0.000 claims description 2
- 102100037132 Proteinase-activated receptor 2 Human genes 0.000 claims description 2
- 101710121435 Proteinase-activated receptor 2 Proteins 0.000 claims description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 2
- 102000011990 Sirtuin Human genes 0.000 claims description 2
- 108050002485 Sirtuin Proteins 0.000 claims description 2
- 206010040904 Skin odour abnormal Diseases 0.000 claims description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 2
- 208000031439 Striae Distensae Diseases 0.000 claims description 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 claims description 2
- 239000002250 absorbent Substances 0.000 claims description 2
- 230000002745 absorbent Effects 0.000 claims description 2
- 102000034337 acetylcholine receptors Human genes 0.000 claims description 2
- 229940022698 acetylcholinesterase Drugs 0.000 claims description 2
- 206010000496 acne Diseases 0.000 claims description 2
- 239000000443 aerosol Substances 0.000 claims description 2
- 230000002776 aggregation Effects 0.000 claims description 2
- 238000004220 aggregation Methods 0.000 claims description 2
- 238000003915 air pollution Methods 0.000 claims description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 claims description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 229940035676 analgesics Drugs 0.000 claims description 2
- 229940035674 anesthetics Drugs 0.000 claims description 2
- 230000033115 angiogenesis Effects 0.000 claims description 2
- 239000000730 antalgic agent Substances 0.000 claims description 2
- 239000003242 anti bacterial agent Substances 0.000 claims description 2
- 230000003712 anti-aging effect Effects 0.000 claims description 2
- 230000001760 anti-analgesic effect Effects 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 claims description 2
- 230000003556 anti-epileptic effect Effects 0.000 claims description 2
- 230000001387 anti-histamine Effects 0.000 claims description 2
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 2
- 230000001166 anti-perspirative effect Effects 0.000 claims description 2
- 230000001139 anti-pruritic effect Effects 0.000 claims description 2
- 230000002682 anti-psoriatic effect Effects 0.000 claims description 2
- 239000001961 anticonvulsive agent Substances 0.000 claims description 2
- 229960003965 antiepileptics Drugs 0.000 claims description 2
- 229940121375 antifungal agent Drugs 0.000 claims description 2
- 239000000739 antihistaminic agent Substances 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 239000003096 antiparasitic agent Substances 0.000 claims description 2
- 229940125687 antiparasitic agent Drugs 0.000 claims description 2
- 239000003213 antiperspirant Substances 0.000 claims description 2
- 239000003908 antipruritic agent Substances 0.000 claims description 2
- 239000003443 antiviral agent Substances 0.000 claims description 2
- 239000002249 anxiolytic agent Substances 0.000 claims description 2
- 239000003212 astringent agent Substances 0.000 claims description 2
- 239000003899 bactericide agent Substances 0.000 claims description 2
- 239000000022 bacteriostatic agent Substances 0.000 claims description 2
- 150000001277 beta hydroxy acids Chemical class 0.000 claims description 2
- 239000011230 binding agent Substances 0.000 claims description 2
- 229920001222 biopolymer Polymers 0.000 claims description 2
- 238000011138 biotechnological process Methods 0.000 claims description 2
- 239000007844 bleaching agent Substances 0.000 claims description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 2
- 230000015556 catabolic process Effects 0.000 claims description 2
- 230000019522 cellular metabolic process Effects 0.000 claims description 2
- 229940106189 ceramide Drugs 0.000 claims description 2
- 150000001783 ceramides Chemical class 0.000 claims description 2
- 239000002738 chelating agent Substances 0.000 claims description 2
- 239000000812 cholinergic antagonist Substances 0.000 claims description 2
- 238000004587 chromatography analysis Methods 0.000 claims description 2
- 230000004087 circulation Effects 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 230000011382 collagen catabolic process Effects 0.000 claims description 2
- 239000003086 colorant Substances 0.000 claims description 2
- 238000006731 degradation reaction Methods 0.000 claims description 2
- 239000002781 deodorant agent Substances 0.000 claims description 2
- 239000007854 depigmenting agent Substances 0.000 claims description 2
- 210000004207 dermis Anatomy 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
- 239000006185 dispersion Substances 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims description 2
- 230000002500 effect on skin Effects 0.000 claims description 2
- 239000003480 eluent Substances 0.000 claims description 2
- 239000003974 emollient agent Substances 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 210000002615 epidermis Anatomy 0.000 claims description 2
- 230000028023 exocytosis Effects 0.000 claims description 2
- 239000004744 fabric Substances 0.000 claims description 2
- 239000000194 fatty acid Substances 0.000 claims description 2
- 229930195729 fatty acid Natural products 0.000 claims description 2
- 150000004665 fatty acids Chemical class 0.000 claims description 2
- 210000002950 fibroblast Anatomy 0.000 claims description 2
- 239000006260 foam Substances 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 239000003205 fragrance Substances 0.000 claims description 2
- 239000003193 general anesthetic agent Substances 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims description 2
- 239000003102 growth factor Substances 0.000 claims description 2
- 239000003966 growth inhibitor Substances 0.000 claims description 2
- 208000024963 hair loss Diseases 0.000 claims description 2
- 230000003676 hair loss Effects 0.000 claims description 2
- 230000035876 healing Effects 0.000 claims description 2
- 239000013003 healing agent Substances 0.000 claims description 2
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 2
- 229920002674 hyaluronan Polymers 0.000 claims description 2
- 229960003160 hyaluronic acid Drugs 0.000 claims description 2
- 239000000017 hydrogel Substances 0.000 claims description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims description 2
- 230000002366 lipolytic effect Effects 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000004973 liquid crystal related substance Substances 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 125000001288 lysyl group Chemical group 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 230000000873 masking effect Effects 0.000 claims description 2
- 230000008099 melanin synthesis Effects 0.000 claims description 2
- 210000002752 melanocyte Anatomy 0.000 claims description 2
- 230000004089 microcirculation Effects 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims description 2
- 210000004080 milk Anatomy 0.000 claims description 2
- 230000001333 moisturizer Effects 0.000 claims description 2
- 235000011929 mousse Nutrition 0.000 claims description 2
- 230000004118 muscle contraction Effects 0.000 claims description 2
- 230000001537 neural effect Effects 0.000 claims description 2
- 239000004745 nonwoven fabric Substances 0.000 claims description 2
- 239000003921 oil Substances 0.000 claims description 2
- 235000019198 oils Nutrition 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 229920000620 organic polymer Polymers 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 230000003711 photoprotective effect Effects 0.000 claims description 2
- 239000000049 pigment Substances 0.000 claims description 2
- 239000000419 plant extract Substances 0.000 claims description 2
- 229920001282 polysaccharide Polymers 0.000 claims description 2
- 239000005017 polysaccharide Substances 0.000 claims description 2
- 239000011148 porous material Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 claims description 2
- 230000009467 reduction Effects 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 210000002374 sebum Anatomy 0.000 claims description 2
- 239000000932 sedative agent Substances 0.000 claims description 2
- 229940125723 sedative agent Drugs 0.000 claims description 2
- 230000037307 sensitive skin Effects 0.000 claims description 2
- 239000002453 shampoo Substances 0.000 claims description 2
- 238000001542 size-exclusion chromatography Methods 0.000 claims description 2
- 230000009759 skin aging Effects 0.000 claims description 2
- 230000037394 skin elasticity Effects 0.000 claims description 2
- 239000000344 soap Substances 0.000 claims description 2
- 235000017281 sodium acetate Nutrition 0.000 claims description 2
- 239000001632 sodium acetate Substances 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 241000894007 species Species 0.000 claims description 2
- 210000000130 stem cell Anatomy 0.000 claims description 2
- 210000000434 stratum corneum Anatomy 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 230000000475 sunscreen effect Effects 0.000 claims description 2
- 239000000516 sunscreening agent Substances 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- 238000013268 sustained release Methods 0.000 claims description 2
- 239000012730 sustained-release form Substances 0.000 claims description 2
- 239000002562 thickening agent Substances 0.000 claims description 2
- 230000001256 tonic effect Effects 0.000 claims description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 2
- 230000008728 vascular permeability Effects 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000000341 volatile oil Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 230000002087 whitening effect Effects 0.000 claims description 2
- 230000037303 wrinkles Effects 0.000 claims description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 claims 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims 1
- -1 serum Substances 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20130382437 EP2868308A1 (en) | 2013-10-30 | 2013-10-30 | Expolysaccharide for the treatment and/or care of skin, culture media and compositions thereof |
| EP13382437.5 | 2013-10-30 | ||
| PCT/EP2014/073401 WO2015063240A1 (en) | 2013-10-30 | 2014-10-30 | Exopolysaccharide for the treatment and/or care of the skin, culture media and compositions thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016535035A JP2016535035A (ja) | 2016-11-10 |
| JP2016535035A5 true JP2016535035A5 (enExample) | 2017-11-24 |
| JP6608817B2 JP6608817B2 (ja) | 2019-11-20 |
Family
ID=49876517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016526866A Active JP6608817B2 (ja) | 2013-10-30 | 2014-10-30 | 皮膚の処置および／またはケアのためのエキソ多糖類、その培養培地ならびに組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10500153B2 (enExample) |
| EP (2) | EP2868308A1 (enExample) |
| JP (1) | JP6608817B2 (enExample) |
| KR (1) | KR102279657B1 (enExample) |
| CN (1) | CN105934231B (enExample) |
| AU (1) | AU2014343701B2 (enExample) |
| BR (1) | BR112016009474B1 (enExample) |
| ES (1) | ES2747124T3 (enExample) |
| MX (1) | MX372655B (enExample) |
| WO (1) | WO2015063240A1 (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102610786B1 (ko) * | 2014-10-28 | 2023-12-05 | 루브리졸 어드밴스드 머티어리얼스, 인코포레이티드 | 할로모나스 발효 추출물을 함유한 미용 조성물, 및 이의 용도 |
| KR102481341B1 (ko) | 2014-10-31 | 2022-12-23 | 루브리졸 어드밴스드 머티어리얼스, 인코포레이티드 | 피부 표면으로 활성 작용제의 전달을 위한 열가소성 폴리우레탄 필름 |
| CN107949368A (zh) | 2015-07-28 | 2018-04-20 | 玫琳凯有限公司 | 局部皮肤用制剂 |
| KR102532172B1 (ko) * | 2015-10-05 | 2023-05-17 | 주식회사 엘지생활건강 | 고염 미생물을 포함하는 화장료 조성물 |
| WO2017079248A1 (en) | 2015-11-05 | 2017-05-11 | Lubrizol Advanced Materials, Inc. | Thermoformable dual network hydrogel compositions |
| FR3044223B1 (fr) * | 2015-11-30 | 2019-05-24 | Laboratoires M&L | Composition cosmetique et utilisation |
| EP3295927A1 (en) | 2016-09-19 | 2018-03-21 | Institut Univ. de Ciència i Tecnologia, S.A. | Uses of an exopolysaccharide-protein complex obtained from a bacterium |
| EP3295926A1 (en) | 2016-09-19 | 2018-03-21 | Institut Univ. de Ciència i Tecnologia, S.A. | Exopolysaccharide-protein complex, a method of preparing said complex and uses thereof |
| FR3061003B1 (fr) * | 2016-12-27 | 2019-05-24 | L'oreal | Composition cosmetique comprenant une dispersion d'huile dans une phase aqueuse gelifiee |
| EP3567645A1 (en) | 2018-05-11 | 2019-11-13 | Murata Manufacturing Co., Ltd. | Porous region structure and method of manufacture thereof |
| CN111088693B (zh) * | 2018-10-22 | 2022-11-18 | 常州柚盾实业投资有限公司 | 一种表面涂布介质体系的改性膜布及其生产方法 |
| CN109825949A (zh) * | 2019-03-11 | 2019-05-31 | 东莞华工创为生物科技有限公司 | 一种全固态功能性纳米纤维膜的制备及应用 |
| CN110664655B (zh) * | 2019-09-20 | 2023-02-28 | 西安博和医疗科技有限公司 | 细胞培养液 |
| CN111358991B (zh) * | 2020-03-24 | 2021-12-21 | 福建省海乐威生物工程有限公司 | 一种鞋袜除臭抗菌组合物及其制备方法 |
| JP2023528152A (ja) * | 2020-04-14 | 2023-07-04 | ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ | 水和性化粧品組成物 |
| CN112043627B (zh) * | 2020-09-04 | 2023-02-03 | 高颜苑科技(深圳)有限责任公司 | 一种毛发生长的氨基酸溶液组合物及其制备方法 |
| KR102512643B1 (ko) * | 2020-10-28 | 2023-03-22 | 에코바이오홀딩스 주식회사 | 바이오황 함유 여액 분획물을 포함하는 알레르기성 질환의 예방, 개선 또는 치료용 조성물 |
| CN112458128B (zh) * | 2020-12-04 | 2022-07-19 | 中国科学院海洋研究所 | 一种海洋盐单胞菌胞外多糖在制备免疫增强剂中的应用 |
| IT202100002285A1 (it) * | 2021-02-03 | 2022-08-03 | Farm Dott Ferretti Stefano | Nuova composizione |
| CN115025129B (zh) * | 2021-03-05 | 2024-04-19 | 葡萄王生技股份有限公司 | 含乳酸杆菌的组合物及其预防及/或改善皮肤老化的用途 |
| JP2024508944A (ja) | 2021-03-08 | 2024-02-28 | エキソポリマー インコーポレイテッド | 局所用のバイオポリマー |
| CN113092650B (zh) * | 2021-04-16 | 2022-04-19 | 云南中烟工业有限责任公司 | 一种卷烟纸中树莓苷的检测方法 |
| CN113403247B (zh) * | 2021-05-14 | 2023-02-14 | 南宁汉和生物科技股份有限公司 | 多粘芽孢杆菌高产胞外多糖培养基及其应用方法 |
| IT202100016622A1 (it) * | 2021-06-24 | 2022-12-24 | Thinking Woman Srl | Formulazione cosmetica con attivita’ antimicrobica sinergica |
| BR102021015486A2 (pt) * | 2021-08-05 | 2023-02-14 | Aché Laboratórios Farmacêuticos S.A. | Composição de nanopartícula lipídica contendo extrato de vitis vinifera, usos cosméticos de uma composição de nanopartícula lipídica contendo extrato de vitis vinifera, produto dermocosmético antioxidante e para prevenir o envelhecimento da pele e método de cuidado da pele |
| GR1010349B (el) * | 2021-09-30 | 2022-12-02 | Σωτηριος Αδαμιδης | Συνθεση κατα της κυτταριτιδας |
| CN114712305B (zh) * | 2022-04-22 | 2023-10-24 | 中南大学 | 一种原位负载二氢杨梅素的bsa凝胶杀菌材料及其制备方法和应用 |
| CN114848575B (zh) * | 2022-05-26 | 2023-09-22 | 仁和全域(上海)大健康研究院有限公司 | 一种精华液及其制备方法 |
| FR3136675A1 (fr) * | 2022-06-17 | 2023-12-22 | Feeligreen | Procédé iontophorétique d’administration d’un principe actif |
| CN115429710A (zh) * | 2022-09-05 | 2022-12-06 | 汕头市奇伟实业有限公司 | 一种含有天然防腐剂的保湿护肤品及其制备方法 |
| CN115844921A (zh) * | 2022-12-15 | 2023-03-28 | 山东省科学院生物研究所 | 一种干巴菌胞外多糖及其应用 |
| CN116850128B (zh) * | 2023-08-22 | 2025-02-07 | 上海尊雅实业有限公司 | 一种微生态调节组合物、制备方法及应用 |
| WO2025137392A1 (en) * | 2023-12-19 | 2025-06-26 | K18, Inc. | Conditioner compositions, cleanser compositions and methods of using the same |
| CN119185120B (zh) * | 2024-08-14 | 2025-07-29 | 广州臻颜化妆品有限公司 | 一种刺梨发酵物的制备方法及其应用 |
| CN119745747B (zh) * | 2024-12-27 | 2025-10-10 | 诺德溯源(广州)生物科技有限公司 | 一种缓解敏感皮肤瘙痒和改善屏障的组合物及应用 |
| CN120605223B (zh) * | 2025-08-11 | 2025-10-14 | 科乐美(广州)生物科技有限公司 | 一种天然来源多糖组合物及其制备方法和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009013240A (ja) * | 2007-07-03 | 2009-01-22 | Chisso Corp | 多糖体、その製造方法及びその用途 |
| WO2009127057A1 (en) * | 2008-04-15 | 2009-10-22 | Innovactiv Inc. | Cosmetic compositions comprising exopolysaccharides derived from microbial mats, and use thereof |
| ES2390033B1 (es) * | 2010-11-30 | 2013-10-31 | Lipotec S.A. | Exopolisacárido para el tratamiento y/o cuidado de la piel, mucosas, cabello y/o uñas. |
-
2013
- 2013-10-30 EP EP20130382437 patent/EP2868308A1/en not_active Withdrawn
-
2014
- 2014-10-30 US US15/032,840 patent/US10500153B2/en active Active
- 2014-10-30 AU AU2014343701A patent/AU2014343701B2/en active Active
- 2014-10-30 MX MX2016005585A patent/MX372655B/es active IP Right Grant
- 2014-10-30 JP JP2016526866A patent/JP6608817B2/ja active Active
- 2014-10-30 ES ES14792493T patent/ES2747124T3/es active Active
- 2014-10-30 CN CN201480071566.1A patent/CN105934231B/zh active Active
- 2014-10-30 EP EP14792493.0A patent/EP3062759B1/en active Active
- 2014-10-30 WO PCT/EP2014/073401 patent/WO2015063240A1/en not_active Ceased
- 2014-10-30 KR KR1020167014228A patent/KR102279657B1/ko active Active
- 2014-10-30 BR BR112016009474-3A patent/BR112016009474B1/pt active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016535035A5 (enExample) | ||
| KR102610786B1 (ko) | 할로모나스 발효 추출물을 함유한 미용 조성물, 및 이의 용도 | |
| JP2018500279A5 (enExample) | ||
| AU2015340458B2 (en) | Cosmetic and/or pharmaceutical composition containing a bacterial extracellular product from pseudoalteromonas antarctica, and use thereof | |
| JP6608817B2 (ja) | 皮膚の処置および／またはケアのためのエキソ多糖類、その培養培地ならびに組成物 | |
| JP2016502550A5 (enExample) | ||
| CA2818723C (en) | Exopolysaccharide produced by pseudoaltermonas sp. useful for the treatment and care of the skin, mucous membranes, hair and/or nails | |
| JP2019502677A5 (enExample) | ||
| JP6175488B2 (ja) | 皮膚、粘膜および／または爪の処置および／またはケアのためのエキソポリサッカライド | |
| JP2013544309A5 (enExample) | ||
| JP2015514721A5 (enExample) | ||
| JP2015514124A5 (enExample) | ||
| JP2016519105A5 (enExample) | ||
| RU2012118581A (ru) | Пептиды, используемые в лечении и/или наблюдении за кожей, слизистыми оболочками и/или волосами, и их применение в косметических или фармацевтических композициях | |
| JP2015514722A5 (enExample) | ||
| JP2015514125A5 (enExample) | ||
| KR20100072000A (ko) | 미용 및/또는 피부과학적 용도의 4-아미디노 벤질아민 | |
| AU2014343701A1 (en) | Exopolysaccharide for the treatment and/or care of the skin, culture media and compositions thereof | |
| JP2013533226A5 (enExample) | ||
| JP2008143903A (ja) | 落屑を促進するためのアニス酸の美容的使用 | |
| EP2976060B1 (en) | Exopolysaccharide for the treatment and/or care of the skin, mucous membranes and/or nails | |
| CN110870880B (zh) | 包含异常毕赤酵母和视黄醇的局部用组合物 | |
| CN110870884A (zh) | 包含异常毕赤酵母和大豆产品的局部用组合物 |